J. Scott Beeler

A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-term Outcome Correlated with Increased Frequency of DNA Damage Response Gene Mutations, TNBC Subtype, AR Status, and Ki67

Bojana Jovanović, Ingrid A. Mayer, Erica L. Mayer et al. · Clinical Cancer Research · 2017 · 147 citations · Full text

Medicine, Oncology, Pharmacology +17

p73 Is Required for Multiciliogenesis and Regulates the Foxj1-Associated Gene Network

Clayton B. Marshall, Deborah J. Mays, J. Scott Beeler et al. · Cell Reports · 2016 · 144 citations · Full text

Life Sciences, Genetics, Molecular Biology +6

Random control clinical trial on the effects of aerobic exercise training on erythrocyte levels during radiation treatment for breast cancer

Jacqueline S. Drouin, Timothy J. Young, J. Scott Beeler et al. · Cancer · 2006 · 74 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitors

Johanna M. Schafer, Brian D. Lehmann, Paula I. González-Ericsson et al. · Science Translational Medicine · 2020 · 73 citations · Full text

Medicine, Cancer Biology, Oncology +15

Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer

Bojana Jovanović, J. Scott Beeler, Michael W. Pickup et al. · Breast Cancer Research · 2014 · 62 citations · Full text

Medicine, Molecular Biology, Oncology +17